This Activity Requires You To Leave myCME.

You are now leaving myCME and connecting to our educational partner. myCME does not control content, practices, or other policies of the site you are entering.

You are about to open a webpage that is outside of this educational content.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
This CME Activity has expired and is no longer available for credit.
Case Study 2: A 29-Year-Old Female Teacher With Cold Sore Recurrences and Systemic Lupus Erythematosus

Case Study 2: A 29-Year-Old Female Teacher With Cold Sore Recurrences and Systemic Lupus Erythematosus

Format

Knowledge

Time to Complete

0.5 Hours

Released

October 1, 2010

Expires

October 31, 2011

Program Description

Recurrent herpes simplex labialis (HSL) is a common condition usually caused by reactivation of herpes simplex virus-1, with lifelong potential for reactivation leading to disease recurrence. As this case highlights, in the immunocompromised host, HSL tends to be more severe and debilitating. This is the second of 3 in-depth case studies on herpes labialis, focusing on different patient populations, degree of severity, inter-related symptoms, differential diagnosis, and different treatment options.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Explain herpes simplex virus (HSV) pathogenesis

  • Describe factors that contribute to the prevalence of initial and recurrent herpes labialis and the social and psychological impact

  • Describe the clinical presentation of herpes labialis, including the various stages of HSV lesions

  • Identify current and emerging treatment options for the management of herpes labialis

  • Explain strategies for patient counseling and education in the prevention and treatment of herpes labialis

Disclosure

Stephen K. Tyring, MD, PhD, MBA, has nothing to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. [Medical Education Resources, Meda Pharmaceuticals, Inc., and Haymarket Medical do not recommend the use of any agent outside of the labeled indications].

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, Meda Pharmaceuticals, Inc., and Haymarket Medical. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

This program is sponsored by Medical Education Resources.

If you have any questions relating to the accreditation of this activity, please contact Tami Good at tami@mer.org.

This program is supported by an educational grant from Meda Pharmaceuticals, Inc.

Faculty

Stephen K. Tyring, MD, PhD, MBA
Clinical Professor
Departments of Dermatology, Microbiology/Molecular Genetics and Internal Medicine
University of Texas Health Science Center
Medical Director of the Center for Clinical Studies
Houston, Texas

Credit

0.50

Type

CE for Pharmacists

Accreditation Statement

Medical Education Resources is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Medical Education Resources designates this continuing education activity for .50 contact hours (0.005 CEUs) of the Accreditation Council for Pharmacy Education. Universal Program Number 816-9999-10-017-H01-P. This activity is certified as knowledge-based CPE.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources and Haymarket Medical Education.

Designation Statement

Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians. Medical Education Resources designates this educational activity for a maximum of .50 AMA PRA category 1 creditTM. Physicians should claim credit commensurate with the extent of their participation in the activity.

Instructions

To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Add to Queue